[Federal Register: December 27, 2007 (Volume 72, Number 247)]
[Notices]               
[Page 73368]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr27de07-84]                         

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

 
Importer of Controlled Substances; Notice of Registration

    By Notice dated August 28, 2007 and published in the Federal 
Register on September 10, 2007, (72 FR 51664), CIMA Labs, Inc., 7325 
Aspen Lane, Brooklyn Park, Minnesota 55428 made application by letter 
to the Drug Enforcement Administration (DEA) to be registered as an 
importer of Nabilone (7379), a basic class of controlled substance 
listed in schedule II.
    The company plans to import the basic class of controlled substance 
for clinical trials and research.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and 952(a) and determined that the 
registration of CIMA Labs, Inc. to import the basic class of controlled 
substance is consistent with the public interest and with United States 
obligations under international treaties, conventions, or protocols in 
effect on May 1, 1971, at this time. DEA has investigated CIMA Labs, 
Inc. to ensure that the company's registration is consistent with the 
public interest. The investigation has included inspection and testing 
of the company's physical security systems, verification of the 
company's compliance with state and local laws, and a review of the 
company's background and history. Therefore, pursuant to 21 U.S.C. 
952(a) and 958(a), and in accordance with 21 CFR 1301.34, the above 
named company is granted registration as an importer of the basic class 
of controlled substance listed.

    Dated: December 18, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
 [FR Doc. E7-25038 Filed 12-26-07; 8:45 am]

BILLING CODE 4410-09-P